These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23175541)

  • 21. Breast cancer after Hodgkin disease: hope for a safer cure.
    Yahalom J
    JAMA; 2003 Jul; 290(4):529-31. PubMed ID: 12876097
    [No Abstract]   [Full Text] [Related]  

  • 22. Late effects of treatment for childhood Hodgkin's disease.
    Travis LB; Curtis RE; Boice JD
    N Engl J Med; 1996 Aug; 335(5):352-3. PubMed ID: 8668223
    [No Abstract]   [Full Text] [Related]  

  • 23. Five-year risk of interval-invasive second breast cancer.
    Lee JM; Buist DS; Houssami N; Dowling EC; Halpern EF; Gazelle GS; Lehman CD; Henderson LM; Hubbard RA
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25904721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiologic features of breast cancer after mantle radiation therapy for Hodgkin disease: a study of 230 cases.
    Allen SD; Wallis MG; Cooke R; Swerdlow AJ
    Radiology; 2014 Jul; 272(1):73-8. PubMed ID: 24666474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast carcinoma in young women previously treated for Hodgkin disease.
    Cook KL; Adler DD; Lichter AS; Ikeda DM; Helvie MA
    AJR Am J Roentgenol; 1990 Jul; 155(1):39-42. PubMed ID: 2112862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Secondary solid tumors after Hodgkin's disease radiotherapy; experience at the Gustave Roussy Institute].
    Cosset JM; Henry-Amar M; Dietrich PY; Socié G; Girinsky T; Hayat M; Tubiana M
    Bull Cancer; 1992; 79(4):387-8. PubMed ID: 1421701
    [No Abstract]   [Full Text] [Related]  

  • 27. [Metachronous tumors of the breast. Mammographic findings].
    Tella S; Occhiato R; Speziale AM; Poggi R; Grasso F; Frasca F; Passariello R
    Radiol Med; 1994 Mar; 87(3):245-9. PubMed ID: 8146360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer risk following irradiation for Hodgkin's disease.
    Clemons M; Loijens L; Goss P
    Cancer Treat Rev; 2000 Aug; 26(4):291-302. PubMed ID: 10913384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The issue of low doses in radiation therapy and impact on radiation-induced secondary malignancies].
    Chargari C; Cosset JM
    Bull Cancer; 2013 Dec; 100(12):1333-42. PubMed ID: 24257106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of the radiation dose and assessment of the risk in mammography screening for early detection of cancer of the breast, in Israel.
    Broisman A; Schlesinger T; Alfassi ZB
    Radiat Prot Dosimetry; 2011 Jan; 143(1):113-6. PubMed ID: 21068021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary breast cancer in Hodgkin's lymphoma survivors.
    Crump M; Hodgson D
    J Clin Oncol; 2009 Sep; 27(26):4229-31. PubMed ID: 19667263
    [No Abstract]   [Full Text] [Related]  

  • 32. Thyroid nodules and survivors of Hodgkin's disease.
    Oeffinger KC; Sklar CA; Hudson MM
    Am Fam Physician; 2003 Sep; 68(6):1016, 1018-9; discussion 1019. PubMed ID: 14524392
    [No Abstract]   [Full Text] [Related]  

  • 33. Breast cancer in women following mantle irradiation for Hodgkin's disease.
    Peters MH; Sonpal IM; Batra MK
    Am Surg; 1995 Sep; 61(9):763-6. PubMed ID: 7661471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reducing second breast cancers: a potential role for prophylactic mammary irradiation.
    Brenner DJ; Shuryak I; Russo S; Sachs RK
    J Clin Oncol; 2007 Nov; 25(31):4868-72. PubMed ID: 17971581
    [No Abstract]   [Full Text] [Related]  

  • 35. Breast cancer and other second neoplasms after childhood Hodgkin's disease.
    Bhatia S; Robison LL; Oberlin O; Greenberg M; Bunin G; Fossati-Bellani F; Meadows AT
    N Engl J Med; 1996 Mar; 334(12):745-51. PubMed ID: 8592547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50-69 years is minimal.
    Hauge IH; Pedersen K; Olerud HM; Hole EO; Hofvind S
    Acta Radiol; 2014 Dec; 55(10):1174-9. PubMed ID: 24311702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers.
    Berrington de Gonzalez A; Berg CD; Visvanathan K; Robson M
    J Natl Cancer Inst; 2009 Feb; 101(3):205-9. PubMed ID: 19176458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammographic density and risk of second breast cancer after ductal carcinoma in situ.
    Habel LA; Capra AM; Achacoso NS; Janga A; Acton L; Puligandla B; Quesenberry CP
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2488-95. PubMed ID: 20929881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Treatment for Hodgkin Lymphoma With Estrogen Receptor Status of Subsequent Breast Cancers.
    Withrow DR; Morton LM; Curtis RE; Schonfeld SJ; Berrington de González A
    JAMA Oncol; 2018 Mar; 4(3):414-416. PubMed ID: 29346498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.
    Wattson DA; Hunink MG; DiPiro PJ; Das P; Hodgson DC; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):344-53. PubMed ID: 25104066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.